Embody Expands Norfolk, Virginia, Headquarters
04/08/2022
The company will add 10,000 square feet to its operation to increase product research and development capabilities.
“Building Embody in the Commonwealth of Virginia and specifically within the City of Norfolk has proven to be an advantage for us,” said Jeff Conroy, Founder and CEO of Embody. “It only makes sense that we expand this relationship as we prepare for significant growth. The advantages for us include access to a technical workforce, strong academic and clinical research partners, our DARPA/DOD partners, and an investor base committed to funding innovation and breakthrough healthcare.”
The Virginia Economic Development Partnership (VEDP) worked with the City of Norfolk to secure the project for Virginia and will support Embody’s job creation through the Virginia Jobs Investment Program (VJIP), which provides consultative services and funding to companies creating new jobs in order to support employee recruitment and training activities. As a business incentive supporting economic development, VJIP reduces the human resource costs of new and expanding companies. VJIP is state-funded, demonstrating Virginia’s commitment to enhancing job opportunities for citizens. The company is also eligible to receive state benefits from the Virginia Enterprise Zone Program, administered by the Virginia Department of Housing and Community Development.
“Embody’s growth in the City of Norfolk demonstrates the strength of research and development, higher education resources, and talent the Hampton Roads region offers innovative medical technology developers,” said Governor Glenn Youngkin. “We look forward to seeing this homegrown Virginia company’s far-reaching impact, advancing the sports medicine field in our Commonwealth and beyond.”
Embody was recently selected to participate in VEDP’s award-winning Virginia Leaders in Export Trade (VALET) Program. VALET is an application-based, two-year global export acceleration program that provides participating companies with assistance from a team of experienced international service providers to help meet their export goals.
“Embody’s next-generation platform for the repair of tendon and ligament injuries has the potential to significantly improve human health and recovery, and we are proud that this cutting-edge company was founded in Virginia as a startup and continues to flourish,” said Secretary of Commerce and Trade Caren Merrick. “The City of Norfolk and the surrounding region provide the assets and workforce pipeline to support Embody’s mission, and we thank the company for creating high-quality jobs and boosting the local economy.”
Founded in 2014, Embody is pioneering the next generation regenerative platform for the repair of tendon and ligament injuries with novel collagen-based bio-fabrication techniques and products for the fast-growing sports medicine market. Funded by more than $20 million in Defense Advanced Research Projects Agency and Department of Defense funding, the privately held company is developing unique biomaterials with an initial focus on orthopedic applications including foot and ankle, rotator cuff, and knee ligament, including ACL (Anterior Cruciate Ligament).
Project Announcements
Little Leaf Farms Plans Coffee County, Tennessee, Production Operations
07/02/2025
White Rock Truss & Components Expands Lee County, Virginia, Operations
07/02/2025
Fox Tank Company Plans Coshocton, Ohio, Operations
07/02/2025
Ascentek Expands Shreveport, Louisiana, Operations
07/02/2025
ProBio Establishes Hopewell, New Jersey, Gene Therapy Operations
07/02/2025
22nd Century Technologies Expands Fairfax County, Virginia, Headquarters Operations
07/02/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
First Person: David Robey, Co-CEO of QTS Data Centers
Q2 2025